Lot Release Certificate View

Lot Release Number 2020-10-21-0271
FDA Registered Product/Generic Name Diphtheria, Tetanus, Pertussis (Acellular Component), Hepatitis B, Poliomyelitis (Inactivated) and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) [DTap-IPV-HepB-Hib]
Brand Name Hexaxim
Dosage Strength -
Dosage Form Suspension for Injection
Registration Number BR-919
Batch/Lot Number T3L77
Packaging Lot Packaging lot: BOX: T3B113V, PFS: T3B11 Needle 25Gx5/8": 1911043, ED: 2024-10-31; Needle 23Gx1": 1908019, ED: 2024-07-31
Product Expiration Date 31 May 2022
Issuance Date 26 October 2020